Article Versions Notes

Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, et al. Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines. 2013; 1(3):262-277. https://doi.org/10.3390/vaccines1030262

Cashman, Kathleen A., Kate E. Broderick, Eric R. Wilkinson, Carl I. Shaia, Todd M. Bell, Amy C. Shurtleff, Kristin W. Spik, Catherine V. Badger, Mary C. Guttieri, Niranjan Y. Sardesai, and et al. 2013. "Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation" Vaccines 1, no. 3: 262-277. https://doi.org/10.3390/vaccines1030262

Cashman, K. A., Broderick, K. E., Wilkinson, E. R., Shaia, C. I., Bell, T. M., Shurtleff, A. C., Spik, K. W., Badger, C. V., Guttieri, M. C., Sardesai, N. Y., & Schmaljohn, C. S. (2013). Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines, 1(3), 262-277. https://doi.org/10.3390/vaccines1030262